Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme

Clinical Trial ID NCT00621686

PubWeight™ 5.47^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00621686

Top papers